E-LIB Suche - Ergebnisse für: Michaelson, M. Dror

1

Cardiac Structural Changes and Declining Cardiorespiratory ..:

Churchill, Timothy W. ; Smith, Matthew R. ; Michaelson, M. Dror...
Journal of the American Society of Echocardiography. 37 (2024) 7 - p. 706-708 , 2024

Link: https://doi.org/10.1016/..

2

Phase I LITESPARK-001 study of belzutifan for advanced soli..:

Jonasch, Eric ; Bauer, Todd M. ; Papadopoulos, Kyriakos P....
European Journal of Cancer. 196 (2024) - p. 113434 , 2024

Link: https://doi.org/10.1016/..

3

The radiopharmaceutical radium-223 has immunomodulatory eff..:

Saylor, Philip J. ; Kozin, Sergey V. ; Matsui, Aya...
Radiotherapy and Oncology. 192 (2024) - p. 110091 , 2024

Link: https://doi.org/10.1016/..

4

Long-term Outcomes of Chemoradiation for Muscle-invasive Bl..:

Dahl, Douglas M. ; Karrison, Theodore G. ; Michaelson, M. Dror...
European Urology Oncology. 7 (2024) 1 - p. 83-90 , 2024

Link: https://doi.org/10.1016/..

5

Prognostic Significance of Immune Cell Infiltration in Musc..:

Rana, Zaker ; Kamran, Sophia C. ; Shetty, Amol C....
European Urology Oncology. , 2024

Link: https://doi.org/10.1016/..

6

Belzutifan plus cabozantinib for patients with advanced cle..:

Choueiri, Toni K ; McDermott, David F ; Merchan, Jaime...
The Lancet Oncology. 24 (2023) 5 - p. 553-562 , 2023

Link: https://doi.org/10.1016/..

7

Phase II Study of Cabozantinib in Patients With Bone Metast..:

Choy, Edwin ; Cote, Gregory M ; Michaelson, M Dror...
The Oncologist. 27 (2022) 7 - p. 600-606 , 2022

Link: https://doi.org/10.1093/..

8

Inhibition of hypoxia-inducible factor-2α in renal cell car..:

Choueiri, Toni K. ; Bauer, Todd M. ; Papadopoulos, Kyriakos P....
Nature Medicine. 27 (2021) 5 - p. 802-805 , 2021

Link: https://doi.org/10.1038/..

9

Outcomes of older men receiving docetaxel for metastatic ho..:

Lage, Daniel E. ; Michaelson, M. Dror ; Lee, Richard J....
Prostate Cancer and Prostatic Diseases. 24 (2021) 4 - p. 1181-1188 , 2021

Link: https://doi.org/10.1038/..

10

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus..:

Hutson, Thomas E. ; Michaelson, M. Dror ; Kuzel, Timothy M....
European Urology. 80 (2021) 2 - p. 162-170 , 2021

Link: https://doi.org/10.1016/..

11

Author Correction: Inhibition of hypoxia-inducible factor-2..:

Choueiri, Toni K. ; Bauer, Todd M. ; Papadopoulos, Kyriakos P....
Nature Medicine. 27 (2021) 10 - p. 1849-1849 , 2021

Link: https://doi.org/10.1038/..

12

The Art of Oncology: COVID-19 Era:

Reynolds, Kerry L. ; Klempner, Samuel J. ; Parikh, Aparna...
The Oncologist. 25 (2020) 11 - p. 997-1000 , 2020

Link: https://doi.org/10.1634/..

13

Clinical and Economic Outcomes of Treatment Sequences for I..:

Ambavane, Apoorva ; Yang, Shuo ; Atkins, Michael B...
Immunotherapy. 12 (2020) 1 - p. 37-51 , 2020

Link: https://doi.org/10.2217/..

14

Cabozantinib Versus Sunitinib for Untreated Patients with A..:

George, Daniel J. ; Hessel, Colin ; Halabi, Susan...
The Oncologist. 24 (2019) 11 - p. 1497-1501 , 2019

Link: https://doi.org/10.1634/..

15

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A..:

Gao, Xin ; McDermott, David F. ; Michaelson, M. Dror
The Oncologist. 24 (2019) 6 - p. 725-727 , 2019

Link: https://doi.org/10.1634/..